| CUH | Name: | 2,3,4-Trihydroxybenzophenone | Formula: | C13 H10 O4 | SMILES: | Oc1ccc(c(O)c1O)C(=O)c2ccccc2 | InChi: | InChI=1S/C13H10O4/c14-10-7-6-9(12(16)13(10)17)11(15)8-4-2-1-3-5-8/h1-7,14,16-17H | Definition date: | 2017-12-05 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | phenyl-[2,3,4-tris(oxidanyl)phenyl]methanone |
|
| CUQ | Name: | [3,4-bis(oxidanyl)phenyl]-phenyl-methanone | Formula: | C13 H10 O3 | SMILES: | Oc1ccc(cc1O)C(=O)c2ccccc2 | InChi: | InChI=1S/C13H10O3/c14-11-7-6-10(8-12(11)15)13(16)9-4-2-1-3-5-9/h1-8,14-15H | Definition date: | 2017-12-05 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | [3,4-bis(oxidanyl)phenyl]-phenyl-methanone |
|
| CUT | Name: | [2,4-bis(oxidanyl)phenyl]-phenyl-methanone | Formula: | C13 H10 O3 | SMILES: | Oc1ccc(c(O)c1)C(=O)c2ccccc2 | InChi: | InChI=1S/C13H10O3/c14-10-6-7-11(12(15)8-10)13(16)9-4-2-1-3-5-9/h1-8,14-15H | Definition date: | 2017-12-05 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | [2,4-bis(oxidanyl)phenyl]-phenyl-methanone |
|
| CWE | Name: | R-naringenin | Formula: | C15 H12 O5 | SMILES: | Oc1ccc(cc1)[CH]2CC(=O)c3c(O)cc(O)cc3O2 | InChi: | InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m1/s1 | Definition date: | 2017-12-11 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | (2~{R})-2-(4-hydroxyphenyl)-5,7-bis(oxidanyl)-2,3-dihydrochromen-4-one |
|
| D9W | Name: | ~{N}-[3-[(3~{R})-5-azanyl-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]phenyl]-5-bromanyl-pyridine-2-carboxamide | Formula: | C17 H17 Br N4 O2 | SMILES: | C[C]1(COCC(=N1)N)c2cccc(NC(=O)c3ccc(Br)cn3)c2 | InChi: | InChI=1S/C17H17BrN4O2/c1-17(10-24-9-15(19)22-17)11-3-2-4-13(7-11)21-16(23)14-6-5-12(18)8-20-14/h2-8H,9-10H2,1H3,(H2,19,22)(H,21,23)/t17-/m0/s1 | Definition date: | 2018-01-11 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | ~{N}-[3-[(3~{R})-5-azanyl-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]phenyl]-5-bromanyl-pyridine-2-carboxamide |
|
| T99 | Name: | ADENOSINE-5'-SP-ALPHA-THIO-TRIPHOSPHATE | Formula: | C10 H16 N5 O12 P3 S | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](S)(=O)O[P](O)(=O)O[P](O)(O)=O)[CH](O)[CH]3O | InChi: | InChI=1S/C10H16N5O12P3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(25-10)1-24-30(23,31)27-29(21,22)26-28(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,31)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-,30+/m1/s1 | Definition date: | 2017-12-17 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-sulfanyl-phosphoryl] phosphono hydrogen phosphate |
|
| E1T | Name: | 1,8-naphthyridine-2-carboxylic acid | Formula: | C9 H6 N2 O2 | SMILES: | OC(=O)c1ccc2cccnc2n1 | InChi: | InChI=1S/C9H6N2O2/c12-9(13)7-4-3-6-2-1-5-10-8(6)11-7/h1-5H,(H,12,13) | Definition date: | 2018-02-09 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | 1,8-naphthyridine-2-carboxylic acid |
|
| E7E | Name: | ~{N}4-[3-(aminomethyl)phenyl]-1~{H}-indole-2,4-dicarboxamide | Formula: | C17 H16 N4 O2 | SMILES: | NCc1cccc(NC(=O)c2cccc3[nH]c(cc23)C(N)=O)c1 | InChi: | InChI=1S/C17H16N4O2/c18-9-10-3-1-4-11(7-10)20-17(23)12-5-2-6-14-13(12)8-15(21-14)16(19)22/h1-8,21H,9,18H2,(H2,19,22)(H,20,23) | Definition date: | 2018-02-26 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | ~{N}4-[3-(aminomethyl)phenyl]-1~{H}-indole-2,4-dicarboxamide |
|
| E7H | Name: | 4-[[(5~{S},7~{R})-3-azanyl-1-adamantyl]carbonylamino]-1~{H}-indole-2-carboxamide | Formula: | C20 H24 N4 O2 | SMILES: | NC(=O)c1[nH]c2cccc(NC(=O)C34C[CH]5C[CH](CC(N)(C5)C3)C4)c2c1 | InChi: | InChI=1S/C20H24N4O2/c21-17(25)16-5-13-14(23-16)2-1-3-15(13)24-18(26)19-6-11-4-12(7-19)9-20(22,8-11)10-19/h1-3,5,11-12,23H,4,6-10,22H2,(H2,21,25)(H,24,26)/t11-,12+,19+,20- | Definition date: | 2018-02-26 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | 4-[[(5~{S},7~{R})-3-azanyl-1-adamantyl]carbonylamino]-1~{H}-indole-2-carboxamide |
|
| E7W | Name: | (1~{R},2~{S})-2-[[4-[[3-(aminomethyl)phenyl]amino]quinazolin-2-yl]amino]cyclohexane-1-carboxylic acid | Formula: | C22 H25 N5 O2 | SMILES: | NCc1cccc(Nc2nc(N[CH]3CCCC[CH]3C(O)=O)nc4ccccc24)c1 | InChi: | InChI=1S/C22H25N5O2/c23-13-14-6-5-7-15(12-14)24-20-16-8-1-3-10-18(16)25-22(27-20)26-19-11-4-2-9-17(19)21(28)29/h1,3,5-8,10,12,17,19H,2,4,9,11,13,23H2,(H,28,29)(H2,24,25,26,27)/t17-,19+/m1/s1 | Definition date: | 2018-02-27 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | (1~{R},2~{S})-2-[[4-[[3-(aminomethyl)phenyl]amino]quinazolin-2-yl]amino]cyclohexane-1-carboxylic acid |
|
| E82 | Name: | 3-[3-(aminomethyl)phenyl]-~{N}-[(1~{S})-1,2,3,4-tetrahydronaphthalen-1-yl]benzamide | Formula: | C24 H24 N2 O | SMILES: | NCc1cccc(c1)c2cccc(c2)C(=O)N[CH]3CCCc4ccccc34 | InChi: | InChI=1S/C24H24N2O/c25-16-17-6-3-9-19(14-17)20-10-4-11-21(15-20)24(27)26-23-13-5-8-18-7-1-2-12-22(18)23/h1-4,6-7,9-12,14-15,23H,5,8,13,16,25H2,(H,26,27)/t23-/m0/s1 | Definition date: | 2018-02-27 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | 3-[3-(aminomethyl)phenyl]-~{N}-[(1~{S})-1,2,3,4-tetrahydronaphthalen-1-yl]benzamide |
|
| E88 | Name: | (2~{S})-2-[[4-[[3-(aminomethyl)phenyl]amino]quinazolin-2-yl]amino]-3-methyl-butanoic acid | Formula: | C20 H23 N5 O2 | SMILES: | CC(C)[CH](Nc1nc(Nc2cccc(CN)c2)c3ccccc3n1)C(O)=O | InChi: | InChI=1S/C20H23N5O2/c1-12(2)17(19(26)27)24-20-23-16-9-4-3-8-15(16)18(25-20)22-14-7-5-6-13(10-14)11-21/h3-10,12,17H,11,21H2,1-2H3,(H,26,27)(H2,22,23,24,25)/t17-/m0/s1 | Definition date: | 2018-02-27 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | (2~{S})-2-[[4-[[3-(aminomethyl)phenyl]amino]quinazolin-2-yl]amino]-3-methyl-butanoic acid |
|
| E8B | Name: | ~{N}-[3-[3-(aminomethyl)phenyl]phenyl]-3-methyl-butanamide | Formula: | C18 H22 N2 O | SMILES: | CC(C)CC(=O)Nc1cccc(c1)c2cccc(CN)c2 | InChi: | InChI=1S/C18H22N2O/c1-13(2)9-18(21)20-17-8-4-7-16(11-17)15-6-3-5-14(10-15)12-19/h3-8,10-11,13H,9,12,19H2,1-2H3,(H,20,21) | Definition date: | 2018-02-27 | Last modified: | 2018-06-01 | Release date: | 2018-06-06 | Identifier: | ~{N}-[3-[3-(aminomethyl)phenyl]phenyl]-3-methyl-butanamide |
|
| MCL | Name: | NZ-(1-CARBOXYETHYL)-LYSINE | Formula: | C9 H16 N2 O4 | SMILES: | NC(CCCCN=C(/C)C(O)=O)C(=O)O | InChi: | InChI=1S/C9H16N2O4/c1-6(8(12)13)11-5-3-2-4-7(10)9(14)15/h7H,2-5,10H2,1H3,(H,12,13)(H,14,15)/b11-6+/t7-/m0/s1 | Definition date: | 2003-09-23 | Last modified: | 2018-05-29 | Identifier: | (E)-N~6~-(1-carboxyethylidene)-L-lysine |
|
| GR5 | Name: | (2aR,4S,4aR,7aR,7bR)-octahydro-2H-1,7-dioxacyclopenta[cd]inden-4-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate | Formula: | C34 H42 F2 N4 O7 S2 | SMILES: | s1c(nc6c1cc(S(=O)(N(CC(O)C(NC(OC2CC4C3C2CCOC3OC4)=O)Cc5cc(cc(c5)F)F)CC(C)C)=O)cc6)NC7CC7 | InChi: | InChI=1S/C34H42F2N4O7S2/c1-18(2)15-40(49(43,44)24-5-6-26-30(14-24)48-33(38-26)37-23-3-4-23)16-28(41)27(11-19-9-21(35)13-22(36)10-19)39-34(42)47-29-12-20-17-46-32-31(20)25(29)7-8-45-32/h5-6,9-10,13-14,18,20,23,25,27-29,31-32,41H,3-4,7-8,11-12,15-17H2,1-2H3,(H,37,38)(H,39,42)/t20-,25-,27-,28+,29-,31+,32+/m0/s1 | Definition date: | 2018-02-09 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | (2aR,4S,4aR,7aR,7bR)-octahydro-2H-1,7-dioxacyclopenta[cd]inden-4-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate |
|
| GR8 | Name: | (2aS,4R,4aS,7aS,7bS)-octahydro-2H-1,7-dioxacyclopenta[cd]inden-4-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate | Formula: | C34 H42 F2 N4 O7 S2 | SMILES: | s1c3c(nc1NC2CC2)ccc(c3)S(=O)(=O)N(CC(C(Cc4cc(F)cc(c4)F)NC(=O)OC5CC7C6C5CCOC6OC7)O)CC(C)C | InChi: | InChI=1S/C34H42F2N4O7S2/c1-18(2)15-40(49(43,44)24-5-6-26-30(14-24)48-33(38-26)37-23-3-4-23)16-28(41)27(11-19-9-21(35)13-22(36)10-19)39-34(42)47-29-12-20-17-46-32-31(20)25(29)7-8-45-32/h5-6,9-10,13-14,18,20,23,25,27-29,31-32,41H,3-4,7-8,11-12,15-17H2,1-2H3,(H,37,38)(H,39,42)/t20-,25-,27+,28-,29-,31+,32+/m1/s1 | Definition date: | 2018-02-09 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | (2aS,4R,4aS,7aS,7bS)-octahydro-2H-1,7-dioxacyclopenta[cd]inden-4-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate |
|
| F3Z | Name: | (3~{R})-1-[2-oxidanylidene-2-[4-(4-pyrimidin-2-ylphenyl)piperazin-1-yl]ethyl]-~{N}-(3-pyridin-4-yl-1~{H}-indazol-5-yl)pyrrolidine-3-carboxamide | Formula: | C33 H33 N9 O2 | SMILES: | O=C(CN1CC[CH](C1)C(=O)Nc2ccc3[nH]nc(c4ccncc4)c3c2)N5CCN(CC5)c6ccc(cc6)c7ncccn7 | InChi: | InChI=1S/C33H33N9O2/c43-30(42-18-16-41(17-19-42)27-5-2-24(3-6-27)32-35-11-1-12-36-32)22-40-15-10-25(21-40)33(44)37-26-4-7-29-28(20-26)31(39-38-29)23-8-13-34-14-9-23/h1-9,11-14,20,25H,10,15-19,21-22H2,(H,37,44)(H,38,39)/t25-/m1/s1 | Definition date: | 2018-05-24 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | (3~{R})-1-[2-oxidanylidene-2-[4-(4-pyrimidin-2-ylphenyl)piperazin-1-yl]ethyl]-~{N}-(3-pyridin-4-yl-1~{H}-indazol-5-yl)pyrrolidine-3-carboxamide |
|
| EN2 | Name: | ~{N}-[3-[(4-fluorophenyl)carbonylamino]propyl]-1-methyl-6-oxidanylidene-pyridine-3-carboxamide | Formula: | C17 H18 F N3 O3 | SMILES: | CN1C=C(C=CC1=O)C(=O)NCCCNC(=O)c2ccc(F)cc2 | InChi: | InChI=1S/C17H18FN3O3/c1-21-11-13(5-8-15(21)22)17(24)20-10-2-9-19-16(23)12-3-6-14(18)7-4-12/h3-8,11H,2,9-10H2,1H3,(H,19,23)(H,20,24) | Definition date: | 2018-01-10 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | ~{N}-[3-[(4-fluorophenyl)carbonylamino]propyl]-1-methyl-6-oxidanylidene-pyridine-3-carboxamide |
|
| EQ4 | Name: | 5'-O-[(R)-(2-amino-1H-imidazol-1-yl)(hydroxy)phosphoryl]guanosine | Formula: | C13 H17 N8 O7 P | SMILES: | P(OCC1OC(C(C1O)O)n3c2N=C(NC(c2nc3)=O)N)(O)(=O)n4ccnc4N | InChi: | InChI=1S/C13H17N8O7P/c14-12-18-9-6(10(24)19-12)17-4-20(9)11-8(23)7(22)5(28-11)3-27-29(25,26)21-2-1-16-13(21)15/h1-2,4-5,7-8,11,22-23H,3H2,(H2,15,16)(H,25,26)(H3,14,18,19,24)/t5-,7-,8-,11-/m1/s1 | Definition date: | 2018-01-25 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | 5'-O-[(R)-(2-amino-1H-imidazol-1-yl)(hydroxy)phosphoryl]guanosine |
|
| EQT | Name: | 4-chloranyl-1~{H}-indazol-3-amine | Formula: | C7 H6 Cl N3 | SMILES: | Nc1n[nH]c2cccc(Cl)c12 | InChi: | InChI=1S/C7H6ClN3/c8-4-2-1-3-5-6(4)7(9)11-10-5/h1-3H,(H3,9,10,11) | Definition date: | 2018-04-10 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | 4-chloranyl-1~{H}-indazol-3-amine |
|
| EQY | Name: | methyl 7-(3,5-difluorophenyl)-5-(pyridin-3-yl)[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate | Formula: | C18 H11 F2 N5 O2 | SMILES: | c2nc1nc(c(c(n1n2)c3cc(cc(c3)F)F)C(OC)=O)c4cccnc4 | InChi: | InChI=1S/C18H11F2N5O2/c1-27-17(26)14-15(10-3-2-4-21-8-10)24-18-22-9-23-25(18)16(14)11-5-12(19)7-13(20)6-11/h2-9H,1H3 | Definition date: | 2018-01-29 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | methyl 7-(3,5-difluorophenyl)-5-(pyridin-3-yl)[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate |
|
| ER7 | Name: | 1-[7-(3-fluorophenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl]ethan-1-one | Formula: | C14 H11 F N4 O | SMILES: | n1c3n(nc1)c(c2cc(ccc2)F)c(c(C)n3)C(C)=O | InChi: | InChI=1S/C14H11FN4O/c1-8-12(9(2)20)13(10-4-3-5-11(15)6-10)19-14(18-8)16-7-17-19/h3-7H,1-2H3 | Definition date: | 2018-01-29 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | 1-[7-(3-fluorophenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl]ethan-1-one |
|
| ER8 | Name: | ~{N}-~{tert}-butyl-2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]ethanamide | Formula: | C23 H28 Cl N5 O3 | SMILES: | CC(C)(C)NC(=O)CN1Cc2ccc(cc2C1=O)c3nc(NC4CCOCC4)ncc3Cl | InChi: | InChI=1S/C23H28ClN5O3/c1-23(2,3)28-19(30)13-29-12-15-5-4-14(10-17(15)21(29)31)20-18(24)11-25-22(27-20)26-16-6-8-32-9-7-16/h4-5,10-11,16H,6-9,12-13H2,1-3H3,(H,28,30)(H,25,26,27) | Definition date: | 2018-04-11 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | ~{N}-~{tert}-butyl-2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]ethanamide |
|
| ERK | Name: | 2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]-~{N}-[(1~{R})-1-phenylethyl]ethanamide | Formula: | C27 H28 Cl N5 O3 | SMILES: | C[CH](NC(=O)CN1Cc2ccc(cc2C1=O)c3nc(NC4CCOCC4)ncc3Cl)c5ccccc5 | InChi: | InChI=1S/C27H28ClN5O3/c1-17(18-5-3-2-4-6-18)30-24(34)16-33-15-20-8-7-19(13-22(20)26(33)35)25-23(28)14-29-27(32-25)31-21-9-11-36-12-10-21/h2-8,13-14,17,21H,9-12,15-16H2,1H3,(H,30,34)(H,29,31,32)/t17-/m1/s1 | Definition date: | 2018-04-11 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | 2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]-~{N}-[(1~{R})-1-phenylethyl]ethanamide |
|
| ERW | Name: | ~{N}-~{tert}-butyl-2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]-~{N}-methyl-ethanamide | Formula: | C24 H30 Cl N5 O3 | SMILES: | CN(C(=O)CN1Cc2ccc(cc2C1=O)c3nc(NC4CCOCC4)ncc3Cl)C(C)(C)C | InChi: | InChI=1S/C24H30ClN5O3/c1-24(2,3)29(4)20(31)14-30-13-16-6-5-15(11-18(16)22(30)32)21-19(25)12-26-23(28-21)27-17-7-9-33-10-8-17/h5-6,11-12,17H,7-10,13-14H2,1-4H3,(H,26,27,28) | Definition date: | 2018-04-11 | Last modified: | 2018-05-25 | Release date: | 2018-05-30 | Identifier: | ~{N}-~{tert}-butyl-2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]-~{N}-methyl-ethanamide |
|